Immuron's fatty liver disease candidate advancing — 4 insights

Immuron is making progress on three clinical trials for IMM-124E, its nonalcoholic steatohepatitis and nonalcoholic fatty liver disease treatment. Here's what you should know. https://www.beckersasc.com/gastroenterology-and-endoscopy/immuron-s-fatty-liver-disease-candidate-advancing-4-insights.html

This category is empty! Please try another category or use our search function to find what you are looking for. If you require further assistance please contact us.